IM Cannabis (IMCC) Change in Receivables (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Change in Receivables of -$293140.7 for Q1 2026, up 70.06% year-over-year from -$172372.6 in Q1 2025, and down 154.36% quarter-over-quarter from $539248.9 in Q4 2025.
IM Cannabis (IMCC) Change in Receivables (2020 - 2026) Analysis & Trends
IM Cannabis' Change in Receivables history runs 7 years deep, the most recent figure standing at -$293140.7 for Q1 2026.
- In Q1 2026, Change in Receivables rose 70.06% year-over-year to -$293140.7; the TTM figure through Mar 2026 stood at $3.7 million (up 163.82% YoY), while the FY2025 annual figure was $2.9 million, up 163.37% from the prior year.
- Change in Receivables for Q1 2026 stood at -$293140.7, down from $539248.9 in the prior quarter.
- The five-year high for Change in Receivables was $3.6 million in Q4 2022, with the low at -$4.4 million in Q2 2024.
- The 5-year median for Change in Receivables is $505285.8 (2022), against an average of $251413.4.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables jumped 433.01% in 2022, then slumped 929.83% in 2025.
- IM Cannabis' Change in Receivables stood at $3.6 million in 2022, then plunged by 44.97% to $2.0 million in 2023, then sank by 30.84% to $1.4 million in 2024, then sank by 60.29% to $539248.9 in 2025, then plunged by 154.36% to -$293140.7 in 2026.
- Business Quant data shows IMCC's Change in Receivables at -$293140.7 in Q1 2026, $539248.9 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | -293,140.69 |
| Mar 31, 2026 | -293,140.69 |
| Dec 31, 2025 | 539,248.88 |
| Dec 31, 2025 | 539,248.88 |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | -979,167.65 |
| Mar 31, 2025 | -979,167.65 |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -4.37 Mn |
| Jun 30, 2024 | -4.37 Mn |
| Mar 31, 2024 | 117,996.00 |
| Mar 31, 2024 | 117,996.00 |